Cargando…
Can urinary exosomes act as treatment response markers in prostate cancer?
BACKGROUND: Recently, nanometer sized vesicles (termed exosomes) have been described as a component of urine. Such vesicles may be a useful non-invasive source of markers in renal disease. Their utility as a source of markers in urological cancer remains unstudied. Our aim in this study was to inves...
Autores principales: | Mitchell, Paul J, Welton, Joanne, Staffurth, John, Court, Jacquelyn, Mason, Malcolm D, Tabi, Zsuzsanna, Clayton, Aled |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631476/ https://www.ncbi.nlm.nih.gov/pubmed/19138409 http://dx.doi.org/10.1186/1479-5876-7-4 |
Ejemplares similares
-
Cross-presentation of the oncofoetal tumor antigen 5T4 from irradiated prostate cancer cells - a key role for Hsp70
por: Salimu, Josephine C, et al.
Publicado: (2014) -
Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblasts
por: Chowdhury, Ridwana, et al.
Publicado: (2014) -
Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes
por: Salimu, Josephine, et al.
Publicado: (2017) -
Prostate stromal cell proteomics analysis discriminates normal from tumour reactive stromal phenotypes
por: Webber, Jason P., et al.
Publicado: (2016) -
Proteomics analysis of vesicles isolated from plasma and urine of prostate cancer patients using a multiplex, aptamer-based protein array
por: Welton, Joanne Louise, et al.
Publicado: (2016)